Description
Recombinant monoclonal antibody to Cavbeta1 Ca2+ channel. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma N7/18.1. This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques.
Target
Cavbeta1 Ca2+ channel
Target Alias Names
N7/18.1R, Voltage-dependent L-type calcium channel subunit beta-1, CAB1, Calcium channel voltage-dependent subunit beta 1
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression